avutometinib (VS-6766) and Defactinib

Drug identity checked against registry records

Also recorded as avutometinib (VS-6766) and VS-6063

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of Avutometinib (VS-6766) + Defactinib in Recurrent KRAS G12V, Other KRAS and BRAF Non-Small Cell Lung CancerNCT04620330VSTMPhase 2Completed2023-08-29Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.